These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. de Veer MJ; Curtis JM; Baldwin TM; DiDonato JA; Sexton A; McConville MJ; Handman E; Schofield L Eur J Immunol; 2003 Oct; 33(10):2822-31. PubMed ID: 14515266 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. Singh JC; Cruickshank SM; Newton DJ; Wakenshaw L; Graham A; Lan J; Lodge JP; Felsburg PJ; Carding SR Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G514-24. PubMed ID: 15499080 [TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Kawai T; Sato S; Ishii KJ; Coban C; Hemmi H; Yamamoto M; Terai K; Matsuda M; Inoue J; Uematsu S; Takeuchi O; Akira S Nat Immunol; 2004 Oct; 5(10):1061-8. PubMed ID: 15361868 [TBL] [Abstract][Full Text] [Related]
8. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Horng T; Barton GM; Flavell RA; Medzhitov R Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors control activation of adaptive immune responses. Schnare M; Barton GM; Holt AC; Takeda K; Akira S; Medzhitov R Nat Immunol; 2001 Oct; 2(10):947-50. PubMed ID: 11547333 [TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Peng G; Wang HY; Peng W; Kiniwa Y; Seo KH; Wang RF Immunity; 2007 Aug; 27(2):334-48. PubMed ID: 17656116 [TBL] [Abstract][Full Text] [Related]
11. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817 [TBL] [Abstract][Full Text] [Related]
12. IL-4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88. Eisenbarth SC; Zhadkevich A; Ranney P; Herrick CA; Bottomly K J Immunol; 2004 Apr; 172(7):4527-34. PubMed ID: 15034070 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors: function and roles in asthma. Zhou LF; Yin KS Chin Med J (Engl); 2004 Nov; 117(11):1709-15. PubMed ID: 15569491 [No Abstract] [Full Text] [Related]
15. Toll and Toll-like proteins: an ancient family of receptors signaling infection. Imler JL; Hoffmann JA Rev Immunogenet; 2000; 2(3):294-304. PubMed ID: 11256741 [TBL] [Abstract][Full Text] [Related]
16. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Pasare C; Medzhitov R Science; 2003 Feb; 299(5609):1033-6. PubMed ID: 12532024 [TBL] [Abstract][Full Text] [Related]
17. Toll-dependent control mechanisms of CD4 T cell activation. Pasare C; Medzhitov R Immunity; 2004 Nov; 21(5):733-41. PubMed ID: 15539158 [TBL] [Abstract][Full Text] [Related]